Abstract:Cancer chemotherapy is confronted with challenges regarding the effective delivery of chemotherapeutics into tumor cells after systemic administration. Herein, we propose a strategy to load drugs into probiotic E. coli Nissle 1917 (EcN) for self-guided navigation to tumor tissues and subsequently release the drugs with in situ transformation into bacterial ghosts (BGs). Chemotherapeutic agent 5-fluorouracil (FU) and macrophage phenotype regulator zoledronic acid (ZOL) are loaded into EcN through electroporation, followed by decoration of Au nanorods on the ECN surface to construct EcNZ/F@Au. High loading levels of 5FU (8.8%) and ZOL (10.5%) are achieved as well as high retention rates of bacterial viability (87%) and motion velocity (88%). Under near infrared (NIR) illumination the photothermal effect of Au nanorods elevates the local temperature to induce the transformation of live EcN into BGs. The created transmembrane channels initiate the gradual drug release from BGs, thus representing the first attempt to control the drug release via a biological evolution. An intermittent NIR illumination causes stepwise increases in the BG formation and drug release, which could implement an external on-off control and spatiotemporal drug release. Self-guided motion of EcN promotes efficient extravasation across blood vessels and preferential accumulation of drugs in tumors. In addition to the chemotherapeutic effect of FU, the local release of ZOL from EcNZ/F@Au enhances valid polarization of tumor-associated macrophages toward the M1 phenotype and an effective production of proinflammatory cytokines, leading to a synergistic efficacy on tumor growth inhibition. Thus, this study demonstrates a feasible strategy to integrate chemotherapy, immunotherapy, and photothermal effects in a concise manner for effective cancer treatment with few side effects. STATEMENT OF SIGNIFICANCE: Bacteria are capable to trace and colonize in hypoxic tumor tissues. Bacterial drug carriers indicate limitations in efficient drug loading and effective release modulation. Herein, we propose a strategy to load drugs into bacteria for self-guided delivery and subsequently release the drugs in tumors with in situ transformation into bacterial ghost (BGs). Drugs are loaded into live bacteria through electroporation and Au nanorods are decorated on the bacterial surface, wherein the photothermal effect, chemotherapy, and immunotherapy are integrated in a concise manner. NIR illmumination of Au nanorods elevates the local temparature, induces the BG tranformation, and activates the spatiotemporal drug release, representing the first attempt of release modulation via a biological evolution.

Programming the lifestyles of engineered bacteria for cancer therapy

Engineered NIR light-responsive bacteria as anti-tumor agent for targeted and precise cancer therapy

Progress of engineered bacteria for tumor therapy

Modular-designed engineered bacteria for precision tumor immunotherapy via spatiotemporal manipulation by magnetic field

Genetically engineered probiotics for an optical imaging-guided tumor photothermal therapy/immunotherapy

Tweak to Treat: Reprograming Bacteria for Cancer Treatment

Sonogenetics-controlled Synthetic Designer Cells for Cancer Therapy in Tumor Mouse Models

Self-adjusting Engineered Probiotic for Targeted Tumor Colonization and Local Therapeutics Delivery

Path to bacteriotherapy: From bacterial engineering to therapeutic perspectives

Bacteria‐Mediated Tumor Therapy via Photothermally‐Programmed Cytolysin A Expression

Engineering of Bacteria for the Visualization of Targeted Delivery of A Cytolytic Anticancer Agent

Bacterial-based cancer therapy: An emerging toolbox for targeted drug/gene delivery

Surface programmed bacteria as photo-controlled NO generator for tumor immunological and gas therapy

Ultrasound-controllable engineered bacteria for cancer immunotherapy

Synergistic Brilliance: Engineered Bacteria and Nanomedicine Unite in Cancer Therapy

Programmable Bacteria‐Based Biohybrids As Living Biotherapeutics for Enhanced Cancer Sonodynamic‐Immunotherapy

Engineering Living Bacteria for Cancer Therapy.

Bacterial navigation for tumor targeting and photothermally-triggered bacterial ghost transformation for spatiotemporal drug release

Material-based engineering of bacteria for cancer diagnosis and therapy

Recent advances in bacteria-mediated cancer therapy

The Rational Engineered Bacteria Based Biohybrid Living System for Tumor Therapy